Racial and Ethnic Differences and Clinical Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Presenting to the Emergency Department
- PMID: 33822023
- PMCID: PMC8083480
- DOI: 10.1093/cid/ciab290
Racial and Ethnic Differences and Clinical Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Presenting to the Emergency Department
Abstract
Background: Since the introduction of remdesivir and dexamethasone for severe COVID-19 treatment, few large multi-hospital-system US studies have described clinical characteristics and outcomes of minority COVID-19 patients who present to the emergency department (ED).
Methods: This cohort study from the Cerner Real World Database (87 US health systems) from 1 December 2019 to 30 September 2020 included PCR-confirmed COVID-19 patients who self-identified as non-Hispanic Black (Black), Hispanic White (Hispanic), or non-Hispanic White (White). The main outcome was hospitalization among ED patients. Secondary outcomes included mechanical ventilation, intensive care unit care, and in-hospital mortality. Descriptive statistics and Poisson regression compared sociodemographics, comorbidities, receipt of remdesivir or dexamethasone, and outcomes by racial/ethnic groups and geographic region.
Results: 94 683 COVID-19 patients presented to the ED. Blacks comprised 26.7% and Hispanics 33.6%. Nearly half (45.1%) of ED patients presented to hospitals in the South. 31.4% (n = 29 687) were hospitalized. Lower proportions of Blacks were prescribed dexamethasone (29.4%; n = 7426) compared with Hispanics (40.9%; n = 13 021) and Whites (37.5%; n = 14 088). Hospitalization risks, compared with Whites, were similar in Blacks (RR: .94; 95% CI: .82-1.08; P = .4) and Hispanics (.99; .81-1.21; P = .91), but risk of in-hospital mortality was higher in Blacks (1.18; 1.06-1.31; P = .002) and Hispanics (1.28; 1.13-1.44; P < .001).
Conclusions: Minority patients were overrepresented among COVID-19 ED patients, and while their risks of hospitalization were similar to Whites, in-hospital mortality risk was higher. Interventions targeting upstream social determinants of health are needed to reduce racial/ethnic disparities in COVID-19.
Keywords: COVID-19; disparities; emergency department; ethnicity; race.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
Comment in
-
Disparities in Coronavirus Disease 2019 Outcomes for African Americans: More Studies Are Warranted.Clin Infect Dis. 2022 Feb 11;74(3):555-556. doi: 10.1093/cid/ciab498. Clin Infect Dis. 2022. PMID: 34038517 Free PMC article. No abstract available.
-
Reply to author.Clin Infect Dis. 2022 Feb 11;74(3):556. doi: 10.1093/cid/ciab499. Clin Infect Dis. 2022. PMID: 34050745 No abstract available.
Similar articles
-
Disparities in COVID-19 hospitalizations and mortality among black and Hispanic patients: cross-sectional analysis from the greater Houston metropolitan area.BMC Public Health. 2021 Jul 6;21(1):1330. doi: 10.1186/s12889-021-11431-2. BMC Public Health. 2021. PMID: 34229621 Free PMC article.
-
Racial and Ethnic Disparities in Receipt of Medications for Treatment of COVID-19 - United States, March 2020-August 2021.MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(3):96-102. doi: 10.15585/mmwr.mm7103e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35051133 Free PMC article.
-
Acute asthma among adults presenting to the emergency department: the role of race/ethnicity and socioeconomic status.Chest. 2003 Sep;124(3):803-12. doi: 10.1378/chest.124.3.803. Chest. 2003. PMID: 12970001
-
Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.JAMA Netw Open. 2020 Sep 1;3(9):e2019795. doi: 10.1001/jamanetworkopen.2020.19795. JAMA Netw Open. 2020. PMID: 32975574 Free PMC article.
-
Racial Disparities-Associated COVID-19 Mortality among Minority Populations in the US.J Clin Med. 2020 Jul 30;9(8):2442. doi: 10.3390/jcm9082442. J Clin Med. 2020. PMID: 32751633 Free PMC article. Review.
Cited by
-
Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020.J Hepatol. 2021 Oct;75(4):848-855. doi: 10.1016/j.jhep.2021.04.052. Epub 2021 May 14. J Hepatol. 2021. PMID: 33992699 Free PMC article.
-
Association of Healthcare Access With Intensive Care Unit Utilization and Mortality in Patients of Hispanic Ethnicity Hospitalized With COVID-19.J Hosp Med. 2021 Nov;16(11):659-666. doi: 10.12788/jhm.3717. J Hosp Med. 2021. PMID: 34730508 Free PMC article.
-
A Framework for Inspiring COVID-19 Vaccine Confidence in African American and Latino Communities.Vaccines (Basel). 2022 Aug 15;10(8):1319. doi: 10.3390/vaccines10081319. Vaccines (Basel). 2022. PMID: 36016207 Free PMC article.
-
Coronavirus Disease-2019 Pneumonia: Clinical Manifestations.Clin Chest Med. 2023 Jun;44(2):227-237. doi: 10.1016/j.ccm.2022.11.006. Epub 2022 Nov 23. Clin Chest Med. 2023. PMID: 37085216 Free PMC article. Review.
-
Role of Oral Intake, Mobility, and Activity Measures in Informing Discharge Recommendations for Hospitalized Inmate and Noninmate Patients With COVID-19: Retrospective Analysis.JMIR Rehabil Assist Technol. 2023 Jun 27;10:e43250. doi: 10.2196/43250. JMIR Rehabil Assist Technol. 2023. PMID: 37224276 Free PMC article.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources